Clinical Trials Browser

Terminated × Daunorubicin × Myeloid × Clear all

NCT00219765 2005-11-28

Safety and Efficacy of Imatinib in Combination With High Dose Chemotherapy for Acute Phase Chronic Myelogenous Patients

Phase 1/2 Terminated

MyeloidOther hematologic neoplasm

Leukemia, Myelogenous, Chronic, BCR-ABL Positive